These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28262147)

  • 21. In vivo observations of a case of chlorpromazine deposits in the cornea using an HRT II Rostock corneal module.
    Toshida H; Uesugi Y; Ebihara N; Murakami A
    Cornea; 2007 Oct; 26(9):1141-3. PubMed ID: 17893554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corneal toxicity with endothelial deposits after prolonged combined use of two phenothiazine antipsychotics.
    López-Herrero F; Contreras-Díaz M; Sánchez-Vicente JL
    Arch Soc Esp Oftalmol (Engl Ed); 2020 Apr; 95(4):e25. PubMed ID: 32143847
    [No Abstract]   [Full Text] [Related]  

  • 23. Long term evolution of the side-effect lens opacities induced by chlorpromazine prolonged therapy.
    Baron JB; Rivoalan Y; Morel P
    Agressologie; 1971; 12(1):57-60. PubMed ID: 5088348
    [No Abstract]   [Full Text] [Related]  

  • 24. Chlorpromazine-induced lenticular opacity.
    Srinivasan K; Gopalakrishna M
    Indian J Pharmacol; 2020; 52(4):339-340. PubMed ID: 33078739
    [No Abstract]   [Full Text] [Related]  

  • 25. Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    Lal S; Bloom D; Silver B; Desjardins B; Krishnan B; Thavundayil J; Thompson T
    J Psychiatry Neurosci; 1993 Jul; 18(4):173-7. PubMed ID: 8104031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asymmetric anterior segment changes induced by chlorpromazine.
    Deluise VP; Flynn JT
    Ann Ophthalmol; 1981 Aug; 13(8):953-5. PubMed ID: 7294636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular adverse effects of common psychotropic agents: a review.
    Richa S; Yazbek JC
    CNS Drugs; 2010 Jun; 24(6):501-26. PubMed ID: 20443647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antipsychotic drug doses in a schizophrenia inpatient unit.
    Galletly CA
    Aust N Z J Psychiatry; 1992 Dec; 26(4):574-6. PubMed ID: 1362051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ocular involvement during prolonged treatment with neuroleptics].
    Nouri A; Cuendet JF
    Schweiz Med Wochenschr; 1968 Oct; 98(43):1708-11. PubMed ID: 4974196
    [No Abstract]   [Full Text] [Related]  

  • 30. Risperidone-induced Pisa syndrome in MS: resolution with lurasidone and recurrence with Chlorpromazine.
    Iuppa CA; Diefenderfer LA
    Ann Pharmacother; 2013 Sep; 47(9):1223-8. PubMed ID: 24259741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular and cutaneous side effects after prolonged chlorpromazine treatment.
    Gombos GM; Yarden PE
    Am J Psychiatry; 1967 Jan; 123(7):872-4. PubMed ID: 6016858
    [No Abstract]   [Full Text] [Related]  

  • 32. Ocular changes occurring with prolonged high dose chlorpromazine therapy. Results from a collaborative study.
    Prien RF; DeLong SL; Cole JO; Levine J
    Arch Gen Psychiatry; 1970 Nov; 23(5):464-8. PubMed ID: 5478574
    [No Abstract]   [Full Text] [Related]  

  • 33. Chlorpromazine-induced cutaneous pigmentation--effect of replacement with clozapine.
    Lal S; Lal S
    J Psychiatry Neurosci; 2000 May; 25(3):281. PubMed ID: 10863889
    [No Abstract]   [Full Text] [Related]  

  • 34. Corneal and lens changes after prolonged treatment with chlorpromazine.
    Sandvig K
    Acta Ophthalmol (Copenh); 1965; 43(5):730-4. PubMed ID: 5898525
    [No Abstract]   [Full Text] [Related]  

  • 35. Re: From chlorpromazine to clozapine--antipsychotic adverse effects and the clinician's dilemma.
    Nardi AE
    Can J Psychiatry; 2004 Nov; 49(11):784; author reply 784. PubMed ID: 15633857
    [No Abstract]   [Full Text] [Related]  

  • 36. [Corneal and lens deposits due to treatment by phenothiazine type neuroleptics].
    Pouget R; Blayac JP; Largey B; Alric R; Castelnau D; Boulet J
    Ann Med Psychol (Paris); 1976 Mar; 1(3):403-7. PubMed ID: 7987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Testing basic visual functions in the evaluation of extrapyramidal side effects of antipsychotic agents].
    Kéri S; Antal A; Szekeres G; Szendi I; Kovács Z; Janka Z; Benedek G
    Orv Hetil; 1998 Feb; 139(5):235-8. PubMed ID: 9489377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agranulocytosis in the course of phenothiazine therapy: case reports.
    Yassa R
    J Clin Psychiatry; 1985 Aug; 46(8):341-3. PubMed ID: 2862136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular changes associated with chlorpromazine therapy. A preliminary report.
    Edler K
    Acta Ophthalmol (Copenh); 1966; 44(3):405-9. PubMed ID: 5953235
    [No Abstract]   [Full Text] [Related]  

  • 40. A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia.
    Cooper SJ; Tweed J; Raniwalla J; Butler A; Welch C
    Acta Psychiatr Scand; 2000 Mar; 101(3):218-25. PubMed ID: 10721870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.